Terkko Navigator / Alimentary Pharmacology & Therapeutics

Venous thromboembolic events in the tofacitinib ulcerative colitis clinical development programme

Assessment of steroid use as a key performance indicator in inflammatory bowel disease—analysis of data from 2385 UK patients

Fine‐scale geographical distribution and ecological risk factors for Crohn's disease in France (2007‐2014)

The emergence of non‐hypervascular hypointense nodules on enhanced MRI in patients with chronic hepatitis C

Standardising the interpretation of liver biopsies in non‐alcoholic fatty liver disease clinical trials

Systematic review with meta‐analysis: automated low‐flow ascites pump therapy for refractory ascites

Raised serum Interleukin‐6 identifies patients with liver cirrhosis at high risk for overt hepatic encephalopathy

Risks of hospitalization for upper gastrointestinal bleeding in selective serotonin reuptake inhibitors users after Helicobacter pylori eradication therapy: a propensity score matching analysis

Endoscopic activity in asymptomatic patients with an ileal pouch is associated with an increased risk of pouchitis

The impact of anti‐TNFα therapy on colectomy rates and corticosteroid treatment among 3001 paediatric and adolescent patients with ulcerative colitis—a nationwide study from 1995 to 2015

Tenofovir disoproxil fumarate reduces hepatocellular carcinoma, decompensation and death in chronic hepatitis B patients with cirrhosis

Review article: the genetics of the human leucocyte antigen region in inflammatory bowel disease

Systematic review with network meta‐analysis: endoscopic techniques for dysplasia surveillance in inflammatory bowel disease

Review article: impact of exercise on physical frailty in patients with chronic liver disease

A stepwise thrombolysis regimen in the management of acute portal vein thrombosis in patients with evidence of intestinal ischaemia

Risk of rebleeding, vascular events and death after gastrointestinal bleeding in anticoagulant and/or antiplatelet users

Elevated serum interleukin‐2 after gluten correlates with symptoms and is a potential diagnostic biomarker for coeliac disease

Systematic review with meta‐analysis: association between vedolizumab trough concentration and clinical outcomes in patients with inflammatory bowel diseases

Characteristics, aetiologies and trends of hepatocellular carcinoma in patients without cirrhosis: a United States multicentre study

Use of proton pump inhibitors and risk of cholangitis: a nationwide cohort study

Review article: Direct‐acting antivirals for the treatment of HCV during pregnancy and lactation: implications for maternal dosing, foetal exposure, and safety for mother and child

Randomised clinical trial: safety, tolerability, pharmacokinetics, and pharmacodynamics of single and multiple oral doses of tegoprazan (CJ‐12420), a novel potassium‐competitive acid blocker, in healthy male subjects

Development of a stratification tool to identify pancreatic intraductal papillary mucinous neoplasms at lowest risk of progression

Increased risk of thiopurine‐related adverse events in elderly patients with IBD

Review article: the role of the autonomic nervous system in the pathogenesis and therapy of IBD

Randomised clinical trial: a placebo‐controlled study of subcutaneous or intradermal NEXVAX2, an investigational immunomodulatory peptide therapy for coeliac disease

Patients with inflammatory bowel disease have an increased risk of myocardial infarction: a nationwide study

The impact of smoking and smoking cessation on disease outcomes in ulcerative colitis: a nationwide population‐based study

Review article: immune checkpoint inhibitors and the liver, from therapeutic efficacy to side effects

Review article: can bugs be drugs? The potential of probiotics and prebiotics as treatment for non‐alcoholic fatty liver disease

Longitudinal non‐adherence predicts treatment escalation in paediatric ulcerative colitis

Systemic arterial blood pressure determines the therapeutic window of non‐selective beta blockers in decompensated cirrhosis

Real‐life study of safety of thiopurine‐allopurinol combination therapy in inflammatory bowel disease: myelotoxicity and hepatotoxicity rarely affect maintenance treatment

Gastric MALT lymphoma in a population‐based study in France: clinical features, treatments and survival

Improvement of non‐invasive markers of NAFLD from an individualised, web‐based exercise program

Review article: diagnosis and management of intestinal failure‐associated liver disease in adults

Systematic review with meta‐analysis: risk factors for thiopurine‐induced leukopenia in IBD

Abnormalities of mucosal serotonin metabolism and 5‐HT3 receptor subunit 3C polymorphism in irritable bowel syndrome with diarrhoea predict responsiveness to ondansetron

The role of hepatitis B core‐related antigen in predicting hepatitis B virus recurrence after liver transplantation

Management of supragastric belching with cognitive behavioural therapy: factors determining success and follow‐up outcomes at 6‐12 months post‐therapy

Depression is associated with non‐alcoholic fatty liver disease among adults in the United States

Review article: the incidence and risk factors for irritable bowel syndrome in population‐based studies

Baseline neutrophil‐to‐lymphocyte ratio predicts response to corticosteroids and is associated with infection and renal dysfunction in alcoholic hepatitis

Earlier discontinuation of TNF‐α inhibitor therapy in female patients with inflammatory bowel disease is related to a greater risk of side effects

Liver injury is most commonly due to hepatic metastases rather than drug hepatotoxicity during pembrolizumab immunotherapy

Review article: biological mechanisms for symptom causation by individual FODMAP subgroups‐ the case for a more personalised approach to dietary restriction

Systematic review and meta‐analysis: risk of new onset IBD with the use of anti‐interleukin‐17 agents

No increased risk of nephrotoxicity associated with 5‐aminosalicylic acid in IBD: a population‐based cohort and nested case‐control study

Significant reduction in heart rate variability is a feature of acute decompensation of cirrhosis and predicts 90‐day mortality

Systematic review with meta‐analysis of over 90 000 patients. Does fast‐track review diagnose colorectal cancer earlier?